Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid.
Elettra
E
Merola
Gabriele
G
Capurso
Davide
D
Campana
Francesco
F
Panzuto
Bruno
B
Monarca
Paola
P
Tomassetti
Gianfranco
G
Delle Fave
D000368:Aged; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000532:radiotherapy*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D007078:Ileal Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*; D008297:Male; D015282:Octreotide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced* / Q000175:diagnosis; D018000:Receptors, Peptide; D014057:Tomography, X-Ray Computed; D015021:Yttrium Radioisotopes
D018000:Receptors, Peptide; D015021:Yttrium Radioisotopes; C496730:90Y-octreotide, DOTA-Tyr(3)-; D015282:Octreotide